We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Sensorion

News List

Sensorion and Novasep Sign Agreement contractpharma
November 06, 2020
Covers the development and manufacturing of AAV vectors, a key step for Sensorion’s gene therapy programs.
Sensorion’s PIP is EMA-approved for two indications pharmaceutical-technology
July 03, 2019
Sensorion has received acceptance from the European Medicines Agency (EMA) on its Paediatric Investigation Plan (PIP) for Arazasetron (SENS-401) in two indications.
Sensorion’s vertigo drug hits tolerability endpoint in phase 2 fiercebiotech
December 26, 2018
A phase 2a trial of Sensorion’s vertigo seliforant has met its primary tolerability endpoint. The trial found the histamine type 4 receptor antagonist had .....
Sensorion and Cochlear Announce Collaboration to Study Combination Therapies for Cochlear Implant Pa biospace
December 20, 2017
Sensorion and Cochlear will evaluate SENS-401 in combination with Cochlear’s cochlear implants in preclinical setting in 2018, with potential mid-stage clinical testing to begin as soon as 2019